Results 271 to 280 of about 350,390 (302)

Lower mortality risk associated with remdesivir plus corticosteroids vs corticosteroids alone for the treatment of patients hospitalized with SARS-CoV-2 infection in the early and later Omicron periods. [PDF]

Am J Health Syst Pharm
Amin AN, Oppelt T, Chandak A, Gottlieb RL, Chima-Melton C, Pettit NN, Kalil AC.   +6 more
europepmc   +1 more source

Social Accounting for Work‐Related Injuries: Towards a Sustainable Management of Social Externalities

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The present study seeks to advance the understanding of the determinants of occupational injuries, thereby enhancing both academic knowledge and decision‐making in the management and implementation of occupational health and safety measures.
Rosa María Cañaveras Perea, Ángel Tejada Ponce, María Pilar Sánchez González   +2 more
wiley   +1 more source

COVID-19 vaccine-associated liver injury and autoimmune hepatitis: a case series. [PDF]

Ann Med Surg (Lond)
Mariyam N, Albitar MH, Shafqat A, FathAlrahman R, Fallatah HI, Abaalkhail F, Zahran AA, AlMahmoud A.   +7 more
europepmc   +1 more source

Calm after the storm; transition from crisis: Iranian nurses' experiences of the COVID-19 pandemic - a qualitative study. [PDF]

BMJ Open
Zirak M, Sadeghian A, Aliafsari Mamaghani E.   +2 more
europepmc   +1 more source

A real-world retrospective analysis comparing the effectiveness of Azvudine and Nirmatrelvir/Ritonavir in COVID-19 patients with diabetes. [PDF]

Sci Rep
Zhu Z, Chen Q, Wang Z, Chen Q, Li X, Liu Y, Lu H, Feng J, Xie M, Dong X, Chen B, Huang J, Zeng X, Zeng Z, Yuan Y, Xu F, Liao X, Liang B, Chen W.   +18 more
europepmc   +1 more source

Azvudine for the treatment of cancer patients with COVID-19: a multicenter, real-world, retrospective, cohort study. [PDF]

BMC Cancer
Li L, Liu W, Wang L, Yang M, Wang J, Li G, Qian G, Zhang S, Liu D, Luo H, Li S, Zhang D, Yu Z, Ren Z.   +13 more
europepmc   +1 more source

Efficacy and safety of remdesivir for patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review of randomized controlled trials.

Indian J Pharmacol
Meena J, Agarwal A, Sandhu A, Pradhan P, Singh M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drugs for the Treatment of COVID-19

2021
Currently, there are no drugs or other therapeutic agents approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19. Current standard of care includes prevention of infection and control measures and supportive care, including supplemental oxygen and, when required, mechanical ventilatory support.
Sagheer Ahmed, Halimur Rehman, Rehan Salar, May Nasser Bin-Jumah, M. Tauseef Sultan, Marius Moga   +5 more
openaire   +1 more source